Skip to main content
Clinical Trials/CTRI/2024/04/065210
CTRI/2024/04/065210
Not yet recruiting
未知

Antibacterial Utilization Study in a Tertiary Care Pediatric Intensive Care Unit with Estimation of Drug Levels of Vancomycin - NI

I0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: K929- Disease of digestive system, unspecifiedHealth Condition 2: N289- Disorder of kidney and ureter, unspecifiedHealth Condition 3: R99- Ill-defined and unknown cause of mortalityHealth Condition 4: A498- Other bacterial infections of unspecified siteHealth Condition 5: G988- Other disorders of nervous systemHealth Condition 6: J22- Unspecified acute lower respiratory infectionHealth Condition 7: I999- Unspecified disorder of circulatory system
Sponsor
I
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
I

Eligibility Criteria

Inclusion Criteria

  • 1\.All consecutive patients in the age group of more than 1 month to 12 years who are newly admitted to the PICU and are started on antibacterial agents.
  • 2\.For estimation of vancomycin levels, 12 patients on vancomycin will be enrolled from amongst the above study participants.

Exclusion Criteria

  • Patients for whom the parents / guardians are not willing to give informed consent for participation will be excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials